No Data
We Think Shanghai Aladdin Biochemical TechnologyLtd (SHSE:688179) Can Stay On Top Of Its Debt
Aladdin: Aladdin\'s third quarter report 2024
Aladdin 2024 Third Quarter Report
shanghai aladdin biochemical technology co.,ltd (688179.SH) released its performance for the first three quarters, with a net income of 72.5692 million yuan, a year-on-year increase of 32.70%.
shanghai aladdin biochemical technology co.,ltd (688179.SH) released the quarterly report for the first three quarters of 2024. During the reporting period, the company achieved revenue of 3...
shanghai aladdin biochemical technology co.,ltd (688179.SH): net income for the first three quarters was 72.5692 million yuan, a year-on-year increase of 32.70%.
Galonn announced its third-quarter report for 2024 on October 30. The company's revenue for the first three quarters was 0.378 billion yuan, a year-on-year increase of 33.54%; the net income attributable to shareholders of the listed company was 72.5692 million yuan, a year-on-year increase of 32.70%; and the basic earnings per share was 0.26 yuan.
shanghai aladdin biochemical technology co.,ltd (688179.SH): intends to increase investment in neoLab.
On October 24th, Glon Hui announced that Shanghai Aladdin Biochemical Technology Co., Ltd. (688179.SH) plans to use its own funds to inject 888,900.00 euros (equivalent to RMB 6.8231 million) into neoLabMiggeGmbH (referred to as the "target company" or "neoLab"), with 6,420.00 euros subscribed as the target company's registered capital and 882,480.00 euros included in the capital reserve. After the capital increase, the company will hold 10.00% equity of the target company. neoLab was established in Heidelberg, Germany in the 1950s and in October 1986.
No Data
No Data